Gaithersburg-based Gene Logic Inc. enters into drug repositioning

Daily Record, The (Baltimore), Aug 28, 2007

Gaithersburg-based Gene Logic Inc. entered into a drug repositioning and development agreement with Solvay Pharmaceuticals to seek alternative development paths for multiple Solvay drug candidates. All of the candidates were discontinued or de- prioritized in clinical trials for reasons other than safety.

The agreement provides for milestones and royalties similar to those paid for development-stage in-licensing deals, discounted to account for Solvay's contribution as the originator of the compound. Solvay Pharmaceuticals is a research-driven group of companies that constitute the Solvay Group, an international chemicals and pharmaceuticals group headquartered in Brussels.